|
More events from AOL Finance »
|
| Q3 (Sep '09) | 2008 | |
| Net profit margin | 13.99% | 9.92% |
| Operating margin | 20.33% | 16.57% |
| EBITD margin | - | 23.39% |
| Return on average assets | 11.23% | 8.41% |
| Return on average equity | 26.41% | 21.45% |
| Employees | 9,757 | - |
| David J. Illingworth | Chief Executive, Executive Director | |
| Adrian N. Hennah | Chief Financial Officer, Executive Director | |
| Mark Augusti | President - Biologics | |
| Joe Woody | President - Advanced Wound Management | |
| Michael G. Frazzette | President - Endoscopy | |
| Joseph M. DeVivo | President - Orthopaedics | |
| R. Gordon Howe | Senior Vice President - Global Planning and Development | |
| Paul R. Chambers | Company Secretary | |
| Elizabeth Bolgiano | Chief Human Resources Officer | |
| John W. Campo | Chief Legal Officer |